
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Advancements in Cancer Immunotherapies
Ruchi Roy, Sunil Kumar Singh, Sweta Misra
Vaccines (2022) Vol. 11, Iss. 1, pp. 59-59
Open Access | Times Cited: 26
Ruchi Roy, Sunil Kumar Singh, Sweta Misra
Vaccines (2022) Vol. 11, Iss. 1, pp. 59-59
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Cancer metabolism and carcinogenesis
Jianqiang Yang, Chloe Shay, Nabil F. Saba, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 33
Jianqiang Yang, Chloe Shay, Nabil F. Saba, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 33
Peptide Hydrogels as Immunomaterials and Their Use in Cancer Immunotherapy Delivery
Natashya Falcone, Menekşe Ermis, Dilara Goksu Tamay, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 27
Closed Access | Times Cited: 24
Natashya Falcone, Menekşe Ermis, Dilara Goksu Tamay, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 27
Closed Access | Times Cited: 24
Recent Developments in Inertial and Centrifugal Microfluidic Systems along with the Involved Forces for Cancer Cell Separation: A Review
A. Farahinia, Wenjun Zhang, Ildikó Badea
Sensors (2023) Vol. 23, Iss. 11, pp. 5300-5300
Open Access | Times Cited: 24
A. Farahinia, Wenjun Zhang, Ildikó Badea
Sensors (2023) Vol. 23, Iss. 11, pp. 5300-5300
Open Access | Times Cited: 24
Next-Generation Immunotherapy: Advancing Clinical Applications in Cancer Treatment
Pankaj Kumar Garg, Siddhika Pareek, Prakash Kulkarni, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6537-6537
Open Access | Times Cited: 8
Pankaj Kumar Garg, Siddhika Pareek, Prakash Kulkarni, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6537-6537
Open Access | Times Cited: 8
Towards a better understanding of human iNKT cell subpopulations for improved clinical outcomes
Alex Look, Daniel Burns, Ivo Tews, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Alex Look, Daniel Burns, Ivo Tews, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Parasites revive hope for cancer therapy
Maha M. Eissa, Ahmed Ebada Salem, Nahla El Skhawy
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
Maha M. Eissa, Ahmed Ebada Salem, Nahla El Skhawy
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
Metabolically activated and highly polyfunctional intratumoral VISTA+ regulatory B cells are associated with tumor recurrence in early-stage NSCLC
Domenico Lo Tartaro, Beatrice Aramini, Valentina Masciale, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Domenico Lo Tartaro, Beatrice Aramini, Valentina Masciale, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
In Situ Programming of CAR-T Cells: A Pressing Need in Modern Immunotherapy
Marta Śledź, Alicja Wojciechowska, Radosław Zagożdżon, et al.
Archivum Immunologiae et Therapiae Experimentalis (2023) Vol. 71, Iss. 1
Open Access | Times Cited: 10
Marta Śledź, Alicja Wojciechowska, Radosław Zagożdżon, et al.
Archivum Immunologiae et Therapiae Experimentalis (2023) Vol. 71, Iss. 1
Open Access | Times Cited: 10
From Diagnosis to Treatment: Exploring the Latest Management Trends in Cervical Intraepithelial Neoplasia
Saloni Gupta, Nikhilesh Nagtode, Vaibhav Chandra, et al.
Cureus (2023)
Open Access | Times Cited: 9
Saloni Gupta, Nikhilesh Nagtode, Vaibhav Chandra, et al.
Cureus (2023)
Open Access | Times Cited: 9
FDG-PET in Chimeric Antigen Receptor T-Cell (CAR T-Cell) Therapy Toxicity: A Systematic Review
Akram Al‐Ibraheem, Ahmed Saad Abdlkadir, Egesta Lopci, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1728-1728
Open Access | Times Cited: 3
Akram Al‐Ibraheem, Ahmed Saad Abdlkadir, Egesta Lopci, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1728-1728
Open Access | Times Cited: 3
Gut microbiota alteration - Cancer relationships and synbiotic roles in cancer therapies
Adekunle Babajide Rowaiye, Gordon C. Ibeanu, Doofan Bur, et al.
The Microbe (2024) Vol. 4, pp. 100096-100096
Open Access | Times Cited: 3
Adekunle Babajide Rowaiye, Gordon C. Ibeanu, Doofan Bur, et al.
The Microbe (2024) Vol. 4, pp. 100096-100096
Open Access | Times Cited: 3
Unveiling the Interplay of Klotho Protein, Chemotherapy-Induced Klotho Protein Deficiency and the Pivotal Role of GLP-1 Agonists like Ozempic in Cancer Survivorship Patient Survival Rate after Chemotherapy Treatment
Maher M. Akl
Cell & Cellular Life Sciences Journal (2024) Vol. 9, Iss. 1, pp. 1-5
Open Access | Times Cited: 2
Maher M. Akl
Cell & Cellular Life Sciences Journal (2024) Vol. 9, Iss. 1, pp. 1-5
Open Access | Times Cited: 2
Microfluidic devices for the isolation and label-free identification of circulating tumor cells
Muhammad Khairil Anwar, Nuno M. Reis, Chi Zhang, et al.
Chemical Engineering Journal (2024) Vol. 499, pp. 156497-156497
Closed Access | Times Cited: 2
Muhammad Khairil Anwar, Nuno M. Reis, Chi Zhang, et al.
Chemical Engineering Journal (2024) Vol. 499, pp. 156497-156497
Closed Access | Times Cited: 2
Financial Toxicity: Unveiling the Burden of Cancer Care on Patients in Rwanda
Fidel Rubagumya, Brooke E. Wilson, Achille Manirakiza, et al.
The Oncologist (2023) Vol. 29, Iss. 3, pp. e345-e350
Open Access | Times Cited: 5
Fidel Rubagumya, Brooke E. Wilson, Achille Manirakiza, et al.
The Oncologist (2023) Vol. 29, Iss. 3, pp. e345-e350
Open Access | Times Cited: 5
Tumor-Infiltrating iNKT Cells Activated through C-Kit/Sca-1 Are Induced by Pentoxifylline, Norcantharidin, and Their Mixtures for Killing murine Melanoma Cells
Maximiliano V.M. Correa-Lara, Israel Lara-Vega, Minerva Nájera-Martínez, et al.
(2023)
Open Access | Times Cited: 2
Maximiliano V.M. Correa-Lara, Israel Lara-Vega, Minerva Nájera-Martínez, et al.
(2023)
Open Access | Times Cited: 2
Metabolically activated and highly polyfunctional intratumoral VISTA+ regulatory B cells are associated with tumor recurrence in early stage NSCLC.
Domenico Lo Tartaro, Beatrice Aramini, Valentina Masciale, et al.
Research Square (Research Square) (2024)
Open Access
Domenico Lo Tartaro, Beatrice Aramini, Valentina Masciale, et al.
Research Square (Research Square) (2024)
Open Access
Strategies to optimize the promise of checkpoint-targeted anti-cancer therapy
Bernardo L. Rapoport, Ronald Anderson
Immunotherapy (2024) Vol. 16, Iss. 9, pp. 565-568
Closed Access
Bernardo L. Rapoport, Ronald Anderson
Immunotherapy (2024) Vol. 16, Iss. 9, pp. 565-568
Closed Access
Transcriptomic analysis-guided assessment of precision-cut tumor slices (PCTS) as an ex-vivo tool in cancer research
Sumita Trivedi, Caitlin M. Tilsed, Maria Liousia, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Sumita Trivedi, Caitlin M. Tilsed, Maria Liousia, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Cytoprotective effect of garlic alone versus co-administration of garlic and resveratrol in adriamycin-induced lung toxicity in albino rat: light microscopic, ultrastructural and immunohistochemical study
Noha A. Rashed, Omnia I. Ismail
Journal of Molecular Histology (2024) Vol. 55, Iss. 5, pp. 835-849
Closed Access
Noha A. Rashed, Omnia I. Ismail
Journal of Molecular Histology (2024) Vol. 55, Iss. 5, pp. 835-849
Closed Access
Comparison of Cytomegalovirus Reactivation in Children After Allogeneic Hematopoietic Cell Transplantation in 2 Transplant Eras
Yu‐Chuan Wen, Yi-Lun Wang, Tsung‐Yen Chang, et al.
Transplantation Proceedings (2024) Vol. 56, Iss. 8, pp. 1878-1884
Open Access
Yu‐Chuan Wen, Yi-Lun Wang, Tsung‐Yen Chang, et al.
Transplantation Proceedings (2024) Vol. 56, Iss. 8, pp. 1878-1884
Open Access
Emerging druggable targets for immune checkpoint modulation in cancer immunotherapy: the iceberg lies beneath the surface
Sakuntala Gayen, Swarupananda Mukherjee, Sandipan Dasgupta, et al.
APOPTOSIS (2024)
Closed Access
Sakuntala Gayen, Swarupananda Mukherjee, Sandipan Dasgupta, et al.
APOPTOSIS (2024)
Closed Access
Progress in modifying and delivering mRNA therapies for cancer immunotherapy
Karan Goel, Isha Chawla, Garima Garima, et al.
Advances in immunology (2024)
Closed Access
Karan Goel, Isha Chawla, Garima Garima, et al.
Advances in immunology (2024)
Closed Access
Cancer-related fatigue among patients with advanced cancer receiving immune-checkpoint inhibitors: a prospective study
Sriram Yennurajalingam, Lisa S. Thomas, Penny Stanton, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 7
Closed Access
Sriram Yennurajalingam, Lisa S. Thomas, Penny Stanton, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 7
Closed Access
Tumor-Infiltrating iNKT Cells Activated through c-Kit/Sca-1 Are Induced by Pentoxifylline, Norcantharidin, and Their Mixtures for Killing Murine Melanoma Cells
Correa Lara Maximiliano, Israel Lara-Vega, Minerva Nájera-Martínez, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1472-1472
Open Access | Times Cited: 1
Correa Lara Maximiliano, Israel Lara-Vega, Minerva Nájera-Martínez, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1472-1472
Open Access | Times Cited: 1
The influence of immunology and anesthesia on cancer
Suo Qin
Theoretical and Natural Science (2023) Vol. 22, Iss. 1, pp. 234-242
Closed Access | Times Cited: 1
Suo Qin
Theoretical and Natural Science (2023) Vol. 22, Iss. 1, pp. 234-242
Closed Access | Times Cited: 1